Donders S[au] - Search Results

Year	Number of Results
1985	1
1991	1
1992	4
1993	4
1997	1
1998	1
2022	1

1

SARS-CoV-2 Risk Quantification Model and Validation Based on Large-Scale Dutch Test Events.

Kolen B, Znidarsic L, Voss A, Donders S, Kamphorst I, van Rijn M, Bonthuis D, Clocquet M, Schram M, Scharloo R, Boersma T, Stobernack T, van Gelder P. Kolen B, et al. Among authors: donders s. Int J Environ Res Public Health. 2022 Jun 13;19(12):7238. doi: 10.3390/ijerph19127238. Int J Environ Res Public Health. 2022. PMID: 35742486 Free PMC article.

2

Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity.

Donders SH, Pieters GF, Heevel JG, Ross HA, Smals AG, Kloppenborg PW. Donders SH, et al. J Clin Endocrinol Metab. 1985 Jul;61(1):56-9. doi: 10.1210/jcem-61-1-56. J Clin Endocrinol Metab. 1985. PMID: 3923032

3

Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.

Meinardi JR, Donders SH. Meinardi JR, et al. Among authors: donders sh. Neth J Med. 1997 Mar;50(3):105-9. doi: 10.1016/s0300-2977(96)00082-4. Neth J Med. 1997. PMID: 9121593

4

Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients.

Donders SH, Lustermans FA, Van Wersch JW. Donders SH, et al. Scand J Clin Lab Invest. 1993 Apr;53(2):179-86. doi: 10.3109/00365519309088405. Scand J Clin Lab Invest. 1993. PMID: 8469917

5

Microalbuminuria in diabetic patients: relationship to lipid, glyco-metabolic, coagulation and fibrinolysis parameters.

van Wersch JW, Donders SH, Westerhuis LW, Venekamp WJ. van Wersch JW, et al. Among authors: donders sh. Eur J Clin Chem Clin Biochem. 1991 Aug;29(8):493-8. doi: 10.1515/cclm.1991.29.8.493. Eur J Clin Chem Clin Biochem. 1991. PMID: 1954304

6

Lipoprotein(a): a hereditary risk factor for atherosclerotic disease.

Donders SH, van Wersch JW. Donders SH, et al. Neth J Med. 1992 Feb;40(1-2):96-104. Neth J Med. 1992. PMID: 1533703 Review. No abstract available.

7

A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report.

van der Heijden M, Donders SH, Cleophas TJ, Niemeyer MG, van der Meulen J, Bernink PJ, de Planque BA, van der Wall EE. van der Heijden M, et al. Among authors: donders sh. J Clin Pharmacol. 1998 Jul;38(7):630-5. doi: 10.1002/j.1552-4604.1998.tb04470.x. J Clin Pharmacol. 1998. PMID: 9702848 Clinical Trial.

8

Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients.

Donders SH, Lustermans FA, van Wersch JW. Donders SH, et al. Blood Coagul Fibrinolysis. 1992 Jun;3(3):249-56. doi: 10.1097/00001721-199206000-00003. Blood Coagul Fibrinolysis. 1992. PMID: 1386533

9

Fibrinolysis factors and lipid composition of the blood in treated and untreated hypertensive patients.

Donders SH, Lustermans FA, van Wersch JW. Donders SH, et al. Blood Coagul Fibrinolysis. 1992 Feb;3(1):61-7. doi: 10.1097/00001721-199202000-00010. Blood Coagul Fibrinolysis. 1992. PMID: 1623120

10

Glycometabolic control, lipids, and coagulation parameters in patients with non-insulin-dependent diabetes mellitus.

Donders SH, Lustermans FA, van Wersch JW. Donders SH, et al. Int J Clin Lab Res. 1993;23(3):155-9. doi: 10.1007/BF02592301. Int J Clin Lab Res. 1993. PMID: 8400336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results